Old news.... I assume that when the FDA granted us "fast-track" status in 2009, the plan was to approve the drug within a couple of years. I guess we have Endo to thank for putting us back on the "slow-track". Four years....and counting. I wonder how much revenue this will cost us in the end. Too bad Endo isnt financially on the hook for all of our burned cash related to this snafu. I also wonder how many lives have been affected because of their folly. All said and done, I am happy to own Bioniche Life Sciences rather than Endo Pharma. Poor buggers have an enormous market cap for how miserably they have been performing as of late....I hope we sign with Pfizer or Sanofi or some other large drug company that's got their game together at least. Should be an interesting Spring. :) Good luck all.